A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

NCT05178576 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Study drug not available for the study duration.

Conditions

Colon Cancer

Interventions

DRUG: Gevokizumab
DIAGNOSTIC_TEST: Signatera test

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]
[object Object]